Beryl Drugs standalone net profit rises 6.67% in the September 2015 quarter

Sales rise 21.62% to Rs 4.05 crore

Net profit of Beryl Drugs rose 6.67% to Rs 0.16 crore in the quarter ended September 2015 as against Rs 0.15 crore during the previous quarter ended September 2014. Sales rose 21.62% to Rs 4.05 crore in the quarter ended September 2015 as against Rs 3.33 crore during the previous quarter ended September 2014. ParticularsQuarter EndedSep. 2015Sep. 2014% Var.Sales4.053.33 22 OPM %7.419.01 -PBDT0.330.26 27 PBT0.200.18 11 NP0.160.15 7

Powered by Capital Market - Live News